Bliss GVS Pharma Limited
₹118.02
INR+1.58(+1.36%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹1326.49 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹1214.72 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
21.14
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.66
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
47.20%
Operating Margin
Operating income as a percentage of revenue
15.85%
Return on Equity
Net income as a percentage of shareholders' equity
7.16%
Revenue (TTM)
Total revenue over trailing 12 months
₹800.17 Cr+2.7%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹137.49 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹5.96-42.699999999999996%
Balance Sheet
Total Cash
Total cash and short-term investments
₹219.84 Cr
Total Debt
Total short-term and long-term debt
₹94.17 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
8.99%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹92.15 - ₹149.6
Beta
Measure of stock's volatility compared to the market
0.96
Shares Outstanding
Total number of shares issued by the company
₹10.53 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.62%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
8.39%